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Abstract 18 
Objectives: Multidrug-resistant (MDR), methicillin-resistant Staphylococcus pseudintermedius 19 
(MRSP) strains have emerged rapidly as major canine pathogens and present serious treatment 20 
issues, and concerns to public health due to their, albeit low, zoonotic potential. A further 21 
understanding of the genetics of  resistance arising from a broadly susceptible backgound of S. 22 
pseudintermedius is needed.  23 
Methods: We sequenced the genomes of 12 S. pseudintermedius isolates of varied sequence 24 
types (ST) and resistance phenotypes.  25 
Results: Nine distinct clonal lineages had acquired either staphylococcal cassette chromosomes 26 
(SCC)mec elements and/or Tn5405-like elements carrying up to five resistance genes (aphA3, 27 
sat, aadE, ermB, dfrG) to generate MRSP, MDR-methicillin sensitive S. pseudintermedius 28 
(MSSP), and MDR-MRSP populations. The most successful and clinically problematic MDR-MRSP 29 
clones, ST68 SCCmecV(T) and ST71 SCCmecII-III, have further accumulated mutations in gyrA 30 
and grlA conferring resistance to fluoroquinolones. Carriage of additional mobile genetic 31 
elements (MGEs) was highly variable suggesting horizontal gene transfer is frequent in S. 32 
pseudintermedius populations. 33 
Conclusions: Importantly, the data suggest that MDR-MRSP evolved rapidly by acquisition of a 34 
very limited number of MGEs and mutations, and that use of many classes of antimicrobials 35 
may co-select for the spread and emergence of MDR and extensively drug resistant strains. 36 
 3 
Antimicrobial stewardship will need to be comprehensive encompassing human medicine and 37 
veterinary disciplines to successfully preserve antimicrobial efficacy.   38 
 4 
Introduction  39 
Antimicrobial resistance has emerged as one of the most important challenges facing human 40 
and veterinary medicine in the 21st century. Animals are major reservoirs for multidrug-41 
resistant (MDR) pathogens including zoonotic bacteria.1, 2 Pet animals, in particular, are 42 
frequently treated with the same antimicrobial classes that are critical in human medicine, 43 
including first and third generation cephalosporins and fluoroquinolones.3 Additionally, pets 44 
often have close contact with humans providing opportunities for evolution of resistance on 45 
either host with subsequent transmission of bacteria between hosts.4-7  46 
S. pseudintermedius is a major opportunistic pathogen in dogs and cats that typically causes 47 
skin and wound infections.8 Methicillin-susceptible S. pseudintermedius (MSSP) isolates 48 
typically have a widely susceptible phenotype, and infections respond well to treatment with 49 
penicillinase-stable β-lactams, lincosamides, fluoroquinolones and potentiated 50 
sulphonamides.9-11 Methicillin-resistant S. pseudintermedius (MRSP) isolates carrying mecA 51 
were first described in 1999,12 and have since spread clonally across North America, Europe and 52 
Asia.13-15 MRSP now account for 20%-47% of all clinical S. pseudintermedius submissions from 53 
dogs and cats in many areas.16-20 More recently, multidrug-resistant (MDR) phenotypes 54 
(resistant to four or more antimicrobial classes) have emerged, dramatically limiting treatment 55 
options, as often all clinically relevant antimicrobial agents are ineffective. Reports of MDR-56 
MRSP infections in humans have highlighted a threat to human health from zoonotic 57 
transmission.21-23  58 
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The genome-wide diversity and the genetic basis underpinning the rapid evolution and 59 
accumulation of antibiotic resistance in S. pseudintermedius is relatively unknown, despite the 60 
sequencing of the genomes of one MDR-MRSP (E140, ST71 SCCmecII-III),26 one MDR-MSSP 61 
(ED99, ST25)27 and one MSSP (HKU10-03, ST308).28 Broad β-lactam resistance in MRSP is 62 
encoded by mecA carried on staphylococcal cassette chromosome (SCC)mec elements that 63 
have been acquired by multiple S. pseudintermedius clonal lineages on multiple independent 64 
occasions.29-31 MDR-MRSP ST68 SCCmecV and MDR-MRSP ST71 SCCmecII-III are the major 65 
clones that have spread in North America since 2003-2004 and Europe since 2005-2006, 66 
respectively and that continue to disseminate globally.14, 15, 32, 32 In this study, we sequenced the 67 
genomes of 12 S. pseudintermedius isolates in order to characterise the population structure of 68 
resistant S. pseudintermedius, compare the gene content between major clonal lineages, 69 
identify the genetic basis of MDR and explain the evolutionary steps leading to the dominant 70 
MDR-MRSP clones.   71 
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Methods 72 
Bacterial isolates  73 
Genomes of 12 S. pseudintermedius isolates from canine infections were sequenced (Table 1). 74 
Isolates had been confirmed as S. pseudintermedius through demonstration of the S. 75 
intermedius group-specific nuc by PCR and as MSSP or MRSP by the absence or presence of 76 
mecA.20 Antimicrobial susceptibility was assessed by disk diffusion tests for penicillin, ampicillin, 77 
amoxicillin/clavulanate, cefalexin, oxacillin, fusidic acid, gentamicin, kanamycin, erythromycin, 78 
clindamycin, tetracycline, trimethoprim, ciprofloxacin and rifampicin according to BSAC 79 
guidelines,33 resistance to oxacillin according to CLSI guidelines.34 Where breakpoints for a 80 
particular antimicrobial agent were not included in these documents, recommendations by the 81 
disk manufacturer were used.  82 
An isolate was classed as MDR if it was resistant to antimicrobials in ≥4 antimicrobial classes.35 83 
Amongst MRSPs, the most extensively drug-resistant isolates from our collection of clinical 84 
European isolates were selected and for further variation within MRSP ST71, we selected 85 
isolates from the UK and from Germany and those with tetracycline resistance and those 86 
without. A MDR ST68 isolates was included to allow comparison of the current two most 87 
successful lineages and two usual clinical MRSPs were included for their lack of MDR phenotype 88 
as they were thought to provide information into the evolutionary events of MDR-MRSP 89 
emergence (Table 1). Three MSSPs were selected on varying resistance phenotypes including 90 
two MDR-MSSP isolates with uncharacterised STs, and one MSSP with an uncharacterised ST. 91 
For PCR reactions, genomic DNA was extracted from overnight cultures grown in brain heart 92 
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infusion broth (Sigma, UK) using the PureElute Bacterial Genomic DNA preparation kit 93 
(EdgeBiosystems, UK) at quarter scale following the standard protocol with the addition of 3l 94 
lysostaphin (5mg/mL, Sigma, UK) to the spheroblast buffer.    95 
Genome sequencing  96 
Overnight cultures were grown in tryptic soy broth (TSB) at 37oC with 200 rpm shaking. 97 
Genomic DNA was extracted from 1 mL of cultures using the MasterPure Gram Positive DNA 98 
Purification Kit (Cambio, UK). This kit is recommended for extraction of total DNA for whole 99 
genome sequencing and has been used in a large number of studies including those assessing 100 
low molecular weight molecules such as plasmids.36-38 Illumina library preparation was carried 101 
out as described.39 Hi-seq sequencing was carried out following the manufacturer’s standard 102 
protocols (Illumina, Inc, USA). Genomes were assembled de novo with Velvet,40  which yielded 103 
on average 135 contigs/genome (Table 1) and contigs were realigned using Mauve41 against 104 
genome ED99 (Accession: CP002478).  Sequencing of the twelve isolates yielded an average 105 
total of 401,011 Kb per run, corresponding to genome coverage of between 118x and 213x 106 
(mean = 151x; Table 1). Nucleotide sequences of the isolates have been deposited in the 107 
European Nucleotide Archive (ENA) (http://www.ebi.ac.uk/ena/) and accession numbers are 108 
shown in Table 1. 109 
Comparative genomics and phylogenetics 110 
Draft genomes were then compared to the three S. pseudintermedius high quality genome 111 
sequences published before June 2013, ED99, HKU10-03 and E140 (26-28), using the Artemis 112 
and ACT genome visualisation tools.42,43 MGEs were characterised by BLAST analysis of unique 113 
genome regions. Comparative genome figures were created using EasyFig.44 Fastq files for the 114 
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isolates were mapped against the S. pseudintermedius genome ED99 using SMALT 115 
(www.sanger.ac.uk/smalt) in order to identify single nucleotide polymorphisms (SNPs), as 116 
previously described.45 SNPs located in MGEs were identified by comparative genomics and 117 
removed from the alignment. Regions of potential recombination were also identified and 118 
removed from the alignment as previous described.46 A maximum likelihood tree was 119 
generated from core genome SNPs (the core genome being defined as regions of the 120 
chromosome not excluded when MGEs and regions of potential recombination were removed) 121 
using RAxML.47 Trees were visualized and annotated using Figtree. Insertion sequence finder 122 
was used to detect IS elements (www-is.biotoul.fr/).  Restriction-enzymes were named 123 
according to rebase.neb.com.48 CRISPRfinder was used to detect and characterise CRISPR 124 
elements (http://crispr.u-psud.fr/Server/).49   125 
Population structure analysis 126 
The sequence type (ST) of each of the isolates was determined using the recently developed 7-127 
gene multi-locus sequence typing method (MLST)(54). The clonal distribution and relatedness 128 
of S. pseudintermedius isolates was assessed using all STs in the MLST database at the time of 129 
analysis (http://pubmlst.org/spseudintermedius/) and eBURST clustering 130 
(http://eburst.mlst.net/).50 131 
Association of MDR phenotype and presence of Tn5405-like elements 132 
The association of the MDR phenotype with the Tn5405-like elements was tested in a further 133 
60 MSSP and 52 MRSP isolates from a collection of clinical canine isolates.51 All strains were 134 
grown on brain heart infusion agar (BHIA) overnight, prior to testing antibiotic 135 
resistance/susceptibility by growth on BHIA plates containing 0.02mg/mL erythromycin, 136 
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0.02mg/mL kanamycin, 0.02mg/mL oxacillin, 0.02mg/mL streptothricin or 0.02mg/mL 137 
trimethoprim. Genomic DNA was extracted as previously described. The presence of Tn5405-138 
like elements was detected by PCR that targeted the transposase gene using forward 139 
(5’AAGCGATTCGATGATTTTGC3’) and reverse primers (5’CCTGGTTTTAGTTGGCCATT3’). PCR 140 
reactions were performed using Bioline MyTaq kit (Bioline, UK) in 50 μL volumes containing 1 141 
pmol forward and reverse primer, 1 x buffer, 0.1 units Bioline MyTaq polymerase, 1uL of DNA 142 
and dH2O.  Reactions were heated to 95 º C for an initial 2 minutes, followed by 35 cycles of 95 143 
ºC for 30 seconds, 60 ºC for 30 seconds and 72 ºC for 30 seconds, followed by of 1 cycle of 72 144 
ºC for 10 minutes.  145 
Results 146 
Population structure of S. pseudintermedius   147 
The 12 study genomes, respresenting the phenotypic groups MSSP (n=1), MRSP (n=2), MDR-148 
MSSP (n=2) and MDR-MRSP (n=7), were compared to previously sequenced S. 149 
pseudintermedius genomes (n=3)(Table 1). All genomes were highly similar to each other, and 150 
sequence divergence was mainly due to SNPs and presence/absence of short genomic regions, 151 
and variation in the presence/absence of MGEs. Reconstruction of the phylogeny using 34,997 152 
high-quality SNPs revealed nine clonal lineages (defined as a group of MLST genotypes in which 153 
each genotype shares at least five loci in common with another member of the group) amongst 154 
the 15 genomes, six of them sequenced for the first time (CC1, CC68, CC258, CC260, CC262 and 155 
CC263). (Figure 1). MRSP isolates were distributed over four clonal lineages (CC71, CC68, CC260 156 
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and CC258), whilst the MDR phenotype (3 MDR-MSSP and 7 MDR-MRSP) was distributed in six 157 
(CC25, CC68, CC71, CC258, CC262 and CC263). The six ST71 isolates only differed by 162 SNPs. 158 
Clustering of 309 STs in the MLST-7 database using the eBURST program confirmed that MRSP 159 
emerged independently in 6/9 major S. pseudintermedius clonal lineages (CC1, CC45, CC68, 160 
CC71, CC84 and CC258) and in numerous doublet or unlinked STs (Figure 2). MRSP phenotypes 161 
existed in the majority of isolates belonging to STs CC45, CC71 and CC258 suggesting that 162 
SCCmec acquisition contributes to clonal lineage expansion. 163 
Multidrug resistance was acquired by successful MDR-MRSP clones through a three-164 
step accumulation of genomic changes  165 
To understand the evolution of multidrug-resistance in S. pseudintermedius, we investigated 166 
the presence and absence of resistance genes in the core and accessory genome, characterised 167 
their presence on each identified MGE by BLAST analysis and compared their association with 168 
resistance phenotype. All phenotypic resistances could be putatively assigned to a genetic 169 
determinant in all isolates. Pairwise alignments of S. pseudintermedius genomes revealed they 170 
are co-linear to each other, and confirmed a stable component of genes found in all strains 171 
(Figure S3). MGEs accounted for up to 8% of the genome, providing evidence of extensive MGE 172 
acquisition.  173 
All methicillin-resistant study strains carried mecA on a SCCmec element (Figures 1 and 4). All 174 
MDR-MRSP ST71 isolates had a homologous copy of the SCCmecII-III element (29), while the 175 
MDR-MRSP ST68 isolate (23929) had a SCCmecV(T) element.14 The MDR-MRSP ST261 isolate, 176 
1726, carried a novel SCCmecIV element that was homologous to an SCCmecIVg element in S. 177 
aureus,52 but possessed an additional nine genes.  MRSP ST260 isolates carried a novel SCCmec 178 
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element that shared blocks of homology to both SCCmecX and SCCmecV (containing a ccrC 179 
gene), however, it was not possible to obtain its full structure from the sequencing data (data 180 
not shown). Pairwise comparison of SCCmec element structures showed element divergence 181 
giving further support to an independent evolution of MRSP on multiple occasions (Figure 4).  182 
Many other resistance genes were located on transposable elements, and all genomes carried 183 
at least two transposons or insertion sequence (IS) elements while tra genes for conjugative 184 
transfer were absent in all (Figure 1).  185 
All eleven MDR isolates carried a large transposable element resembling Tn5405-like 186 
elements.53,54  This element carried up to five antimicrobial resistance genes aphA3-sat-aadE-187 
dfrG-erm(B) encoding resistance to aminoglycosides (including kanamycin, neomycin and 188 
amikacin), streptothricin, trimethoprim and erythromycin and was present in 8/8 MDR-MRSP 189 
and 3/3 MDR-MSSP isolates (Figures 1 and 5). Pairwise comparison revealed all Tn5405-like 190 
elements were integrated at the same core genome loci. Variation was seen in carriage of dfrG 191 
and cat (Figure 5), truncated versions were found in MDR-MSSP isolates GL118B and ED99, and 192 
one was located on a plasmid (GL117B).  193 
Screening the larger collection of 60 MSSP and 52 MRSP, Tn5405-like elements were present in 194 
8/11 (73%) MDR-MSSP and in all 46 (100%) MDR-MRSP and the MDR phenotype was found in 195 
11/60  (18.3%) MSSP isolates and 46/52 (88.5%) MRSP isolates. Carriage of Tn5405-like 196 
elements  was associated with the MDR phenotype (p<0.001, χ2 test). 197 
Additional resistance genes were present on transposons or IS elements integrated in the core 198 
S. pseudintermedius genome (Figure 1). The tetracycline resistance gene tet(M) was present on 199 
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Tn5801 and Tn916 elements in three and five genomes, respectively. All but one genome 200 
carried at least one blaZ gene, encoding resistance to penicillin, either on Tn552 and/or on 201 
Tn554-like elements. Finally, the aac-aph gene, encoding resistance to gentamicin, was located 202 
on IS256 or IS1272 elements in seven and two genomes, respectively. The cadA gene, encoding 203 
resistance to cadmium, was located on IS431 elements in four genomes.  204 
Plasmids do not appear to play a role in the emergence of MRSP. In this study, 12/15 genomes 205 
carried the integrated plasmid first described in ED99,27 but this plasmid did not carry any 206 
resistance genes. GL117B possessed an additional plasmid with a replication (rep) gene with 207 
97% homology to plasmid pUB112 from S. aureus, and resistance genes aphA-sat-aadE-ermB 208 
similar to the truncated version of the Tn5405-like element (Figure 5). There was no further 209 
evidence for the carriage of plasmid replication (rep) genes in any of the S. pseudintermedius 210 
genomes.  211 
Of core genome mutations described to confer antimicrobial resistance in S. 212 
pseudintermedius,80 individual mutations were present in all strains irrespective of their 213 
phenotype. However, only the six isolates phenotypically resistant to fluoroquinolones (all 214 
MDR-MRSP ST71 and the MDR-MRSP ST68 isolate), representing the most successful MDR-215 
MRSP clones, had mutations gyrA S84L and grlA S80I simultaneously (Figure 1). Mutations in 216 
folP causing sulphonamide resistance are described in S. aureus.57 However, of the eight strains 217 
(including ED99) showing phenotypic resistance to trimethoprim/sulfamethoxazole, the 218 
clinically relevant combination product available for veterinary use, only one strain (23923) 219 
showed folP mutations. Instead, in vitro resistance was more often correlated with the carriage 220 
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of dfrG on Tn5405-like elements (5/8 strains). Only the successful MDR-MRSP ST68, 23929, was 221 
phenotypically resistant to fusidic acid using BSAC breakpoints.33 In S. aureus, fusA mutations 222 
cause low-level resistance to fusidic acid.58, 59 Isolate 23929 had three non-synonymous 223 
mutations in fusA (A376V, I461V and V90I), while only 1 other strain had a fusA mutation 224 
(V90I). No strains carried the MGE-encoded fusB, fusC or fusD. This data indicates that 225 
mutations at sites 376 and 461 are implicated in phenotypic resistance to fusidic acid. 226 
Comparison of fitness factors in the genomes 227 
The successful survival and spread of MDR-MRSP ST71 and MDR-MRSP ST68 are likely depend 228 
on factors that influence colonisation or disease and other fitness factors that might influence 229 
survival and evolutionary success were widely distributed (Figure 1). Prophages were present in 230 
all S. pseudintermedius genomes except ED99, and were integrated into eight chromosomal 231 
locations (Figure 1). All MDR-MRSP ST71 isolates possessed three homologous prophages 232 
without evidence for loss/acquisition of additional prophages. The MDR-MRSP ST68 isolate 233 
possessed four prophages, whilst all other strains possessed only one prophage in their 234 
genome. Prophage genomes were diverse, with few shared genes, and chromosome 235 
integration sites differed (Figure S1). Genes encoding virulence associated protein E (VirE) and a 236 
surface protein with LPxTG motif were located on some prophages, but genes homologous to 237 
Panton-Valentine leukocidin (PVL) toxin were not found.  238 
S. pseudintermedius pathogenicity island (SpPI)1, described in ED99, was present in all genomes 239 
except 1726 (Figure 1). SpPI1 variants existed (Figure 1 and Figure S2), but all shared the same 240 
integrase gene and the same core genome integration site.  Hypothetical proteins were 241 
identified but none related to known virulence factors. 242 
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Potential virulence genes described in Staphylococcus intermedius group (SIG) isolates such as 243 
surface proteins, exoenzymes and toxins including novel toxins Se-int, the β-hemolysin and 244 
exfoliative toxins53 were found in some but not all genomes.  Four of 18 genes encoding surface 245 
proteins that adhere to extracellular matrix factors (spsF, spsO, spsP and spsQ)60-63 were absent 246 
in some genomes (Figure 1). All surface protein genes were variable (non-synonymous and 247 
Indel variation) between lineages, with the most variation present in spsD, spsF, spsJ, spsK, 248 
spsL, spsO and spsP. There was no variation in the surface protein genes within ST71 isolates. 249 
Six of the seven exoenzyme genes (coa, lip, geh, htrA, nuc and clpX) were present in all 250 
genomes, whereas nanB encoding sialidase was present in only 5/15 genomes (Figure 1). Three 251 
of the four toxin genes (hlb, se-int and speta) were present in all genomes; in contrast lukF-I 252 
was present in only 9/15 S. pseudintermedius genomes (Figure 1). Genes encoding all previously 253 
identified two-component regulatory systems (agrA, agrB, agrC, agrD, saeS, saeR, srrA, srrB, 254 
arlS, arlR, lytS and lytR) and SarA protein families (sarA, sarR, sarZ and rot) were present in all 255 
genomes (Figure 1). Collectively, this data indicates that variation in virulence factors in the 256 
core genome is common in S. pseudintermedius, and possibly lineage-associated as in S. aureus.  257 
Barriers to horizontal gene transfer in S. pseudintermedius 258 
The success of particular lineages and/or clones, such as the major MDR-MRSP clones, may also 259 
depend on their ability to acquire novel MGEs through horizontal gene transfer (HGT). 260 
Restriction-modification (R-M) systems and competence genes comG and comE were present in 261 
all genomes irrespective of antimicrobial resistance. All isolates showed evidence of a type I R-262 
M system that we therefore call Sps1, and is also known as SpsE140ORFAP (rebase.neb.com).  A 263 
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full intact type I Sps1 R-M system, containing restriction (hsdR), modification (hsdM) and 264 
specificity (hsdS) genes, was present in the core genome of 11/15 S. pseudintermedius genomes 265 
(Figure 1). In contrast, incomplete systems that are predicted to be non-functional were 266 
present in the remaining genomes. HKU10-03 (ST308) possessed hsdR and hsdM, but no hsdS, 267 
4639949 (ST309) possessed hsdM only, whilst ED99 (ST25) and GL118B (ST262) possessed 268 
truncated hsdR genes. Two types of hsdS variant in the type I R-M systems existed, whilst hsdR 269 
sequences and hsdM sequences were highly homologous across all genomes (Figure 1). These 270 
data suggest that the two clusters of lineages modify their DNA at different target sites, 271 
restricting horizontal transfer of DNA and divergent evolution of S. pseudintermedius into at 272 
least two populations.64 Additionally, a second type I R-M system was carried on all SCCmecII-III 273 
elements of MDR-MRSP ST71 genomes and on the SCCmecIV element of the MDR-MRSP ST261 274 
genome (Figure 1, Figure 4). The hsdS, hsdM and hsdR sequences from the SCCmec elements 275 
were highly homologous, but different from the sequences of respective core genome genes, 276 
and has been called SpsE140ORFGP. Predicted intact type II R-M systems, containing hsdM and 277 
hsdR genes were present in 6/15 genomes (Figure 1) at four different locations: (i) adjacent to 278 
orfX in MDR-MSSP ST25 (ED99)(Sps99ORF30P with a predicted cutsite of CTRYAG) and MSSP 279 
ST309 (4639949) genomes, (ii) adjacent to the phoB gene in the MSSP ST308 (HKU10-03) 280 
(SpsORF2234P with a predicted cutsite of CCNGG) and MRSP ST260 genomes (BNG1 and BNG3), 281 
(iii) at the type I R-M system locus in MDR-MRSP ST68 (23929) (called Sps68ORF1551), and (iv) 282 
on the SCCmecIV and novel SCCmec elements of MDR-MRSP ST68 (23929) and MRSP ST260 283 
(BNG1 and BNG2) genomes (called SpsORF2234P), respectively , and was homologous to the 284 
type II system present at the phoB site.  285 
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Clustered regularly interspaced short palindromic repeats (CRISPR) systems were detected in 286 
3/15 genomes (Figure 1). Six of the 22 spacers in CRISPR from ED99 were homologous to 287 
bacteriophage and plasmids,27 suggesting this isolate is immune to uptake of specific elements 288 
encoding these sequences. Two of the 24 spacers in CRISPR from GL118B were homologous to 289 
bacteriophage, and 2/13 spacers in the CRISPR system found on SCCmecV(T) in 23929 were 290 
homologous to bacteriophage and plasmids. There was no evidence that CRISPR has recognised 291 
important SCCmec or transposons and MDR-MRSP ST71 and ST68 did not have greater or fewer 292 
R-M or CRISPR systems than other strains. 293 
Discussion  294 
Identifying the whole genome characteristics of MDR-MRSP is critical to explain the evolution 295 
and rapid emergence of successful clones. We have shown that only a three-step accumulation 296 
of an SCCmec element, Tn5405-like elements and SNPs in gyrA/grlA was required for the 297 
emergence of the two globally successful MDR-MRSP clones. At the same time, these MDR-298 
MRSP have successfully spread worldwide, indicating that selection for survival of these 299 
resistant isolates is common.  300 
Multiple SCCmec elements have now been sequenced  in S. pseudintermedius.26, 29, 68-71 They 301 
have given rise to multiple MRSP clones and we now report MRSP phenotypes in six of nine 302 
major lineages. The wide distribution of MRSP phenotypes in STs from CC45, CC71 and CC258 303 
suggests that SCCmec elements were acquired ancestrally or that these lineages can acquire 304 
and spread SCCmec more effectively. SCCmec elements of S. pseudintermedius most closely 305 
matched SCCmec elements from S. aureus (SCCmecII-III, SCCmecIV and SCCmecV(T)) and/or 306 
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from coagulase-negative staphylococci (CNS) such as S. epidermidis (SCCmecII-III) and S. 307 
haemolyticus (ΨSCCmec57395), supporting a role of HGT from CNS in MRSP emergence.   308 
The acquisition of the Tn5405-like elements, encoding multiple antimicrobial resistances 309 
simultaneously was a consistent feature of the MDR phenotype seen in both MSSP and MRSP. 310 
Tn5405-like elements have been acquired by at least four S. pseudintermedius lineages, with 311 
variants also found in an additional two lineages. Driving pressures for the selection of Tn5405-312 
like elements remain unclear as antimicrobial prescribing data for pets are available for only a 313 
few countries and the antimicrobial agents encoded on this element seem of little veterinary 314 
clinical relevance.  Nevertheless, the use of only one antimicrobial could be sufficient to select 315 
for the survival of clones with Tn5405-like transposons and resistance to four classes of 316 
antimicrobial. Acquisition of specific gyrA/grlA SNPs associated with phenotypic resistance to 317 
fluoroquinolones is strongly correlated with  the globally successful MDR-MRSP lineages. 14,69 318 
Several fluoroquinolones were authorised for use in pets and have been widely used since the 319 
late 1980s suggesting a key role of fluoroquinolones in promoting survival and spread of MRSP. 320 
A similar association has been reported between fluoroquinolone resistance and the pandemic 321 
spread of major hospital-associated MRSA clones.25, 65, 74 322 
The variation in distribution of other resistance genes and potential fitness factors suggests a 323 
genomic plasticity provided by transposons and suggests that HGT of transposons is frequent in 324 
S. pseudintermedius.14, 75-77 Though prophages were present in all genomes (except ED99), 325 
MDR-MRSP ST71 and ST68 strains contained most prophages suggesting a potential role of 326 
prophages in the fitness of MRSP.  327 
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Although HGT mechanisms have been poorly studied in S. pseudintermedius, the frequent 328 
carriage of prophages makes it likely that transfer is predominantly by bacteriophage 329 
transduction rather than plasmid conjugation, in contrast to S. aureus.24, 78 Experimental studies 330 
are required to test whether the prophage are capable of performing generalised transduction, 331 
and whether transformation occurs in S. pseudintermedius strains. 332 
The distribution of type I and/or type II R-M systems, known barriers to HGT in S. aureus, 333 
suggested that MDR-MRSP genomes are no more efficient or inefficient in acquiring MGE-334 
encoded resistance. R-M systems were present on all SCCmec elements in this study, and also 335 
on ΨSCCmec57395 from a previously described MDR-MRSP ST45.69 To determine if populations 336 
are evolving independently, future studies could assess the extent of recombination occurring 337 
within and between S. pseudintermedius populations. As CRISPR systems were rare in genomes, 338 
and spacer sequences did not match any known SCCmec elements or transposons, it is unlikely 339 
that CRISPRs have a major role in governing HGT of resistance genes in S. pseudintermedius. 340 
Overall, ED99 carried the fewest R-M systems and no prophage, and is potentially an 341 
appropriate laboratory strain for genetic manipulation.  342 
We conclude that MDR-MRSP evolved rapidly through step-wise accumulation of SCCmec, 343 
Tn5405-like elements and SNPs conferring fluoroquinolone resistance. Thus, this study 344 
indicates that the use of only a small number of antimicrobials may select for the pandemic 345 
spread of MDR strains. In particular, a unifying feature of the fittest clones, MDR-MRSP ST68 346 
and MDR-MRSP ST71, was their fluoroquinolone resistance through core genome mutations, 347 
mirroring the success of hospital-associated MRSA clones, such as MRSA CC22. These findings 348 
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have implications for public health as they raise concern over additive selection pressure on 349 
zoonotic bacteria since antimicrobial classes used in pet animals are the same as those critical 350 
in human medicine. Therefore stewardship needs to be comprehensive and include medical 351 
and veterinary healthcare in order to successfully preserve antimicrobial efficacy. 352 
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Figure Legends 587 
Figure 1. Phylogenetic relationships and resistance and genomic features. The phylogenetic 588 
relationship of the S. pseudintermedius genomes based on SNP clustering is shown at the top of 589 
each figure. Strain names are coloured according to their phenotypic group, MSSP = light blue, 590 
MDR-MSSP = dark blue, MRSP = pink, MDR-MRSP = red. Grey or coloured bars indicate 591 
phenotypic resistance or presence of genetic marker, whilst white indicates susceptibility or 592 
absence. A) Phenotypic antibiotic resistance profiles and genetic resistance markersMGEs of 593 
the same type integrated at the same chromosomal loci unless stated. SCCmecA elements  are 594 
SCCmecII-III (grey), SCCmecV(T) (blue), SCCmecIV (yellow) and a unique SCCmec (green), with 595 
homology to SCCmecX and SCCmecV; structural differences are shown in Figure 4. Tn5405-like 596 
elements carried aphA3-sat-aadE-ermB-dfrG (grey), aphA3-sat-aadE-ermB (blue), aphA3-sat-597 
aadE (yellow) or aphA3-sat-aadE-cat (green); structural differences are shown in Figure 5.  All 598 
Tn5801  carried tetM. All Tn916  carried tetM but were integrated into three different sites on 599 
the genome (1, 2 or 3).  All Tn552 and Tn554-like carried blaZ.  All IS256 and IS1272 carried aac-600 
aph.  All IS431 carried cadA.  SNPs associated with antimicrobial resistance to fluoroquinolones 601 
(gyrA and grlA) and fusidic acid (fusA). B) Content of other factors influencing fitness, survival 602 
and horizontal gene transfer (HGT). MGEs of the same type integrated at the same 603 
chromosomal loci unless stated. Three SpPI1 variants (grey, blue, yellow), two bacteriophage 604 
phi1 variants (grey, blue) and three phi3 variants (grey, blue, yellow) were detected. Genes 605 
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encoding surface proteins, exoenzymes, toxins and regulatory systems are indicated. Barriers to 606 
horizontal gene transfer (HGT) were restriction-modification (R-M) or clustered regularly 607 
interspaced short palindromic repeats (CRISPR) systems. Two hsdS variants of type I R-M core 608 
were detected (grey, blue). This figure appears in colour in the online version of JAC and in 609 
black and white in the print version of JAC. 610 
Figure 2. Population structure of Staphylococcus pseudintermedius. Clusters of related STs and 611 
individual unlinked STs within the entire S. pseudintermedius MLST database are shown as an 612 
eBURST diagram. Clusters of linked STs (black lines) correspond to clonal complexes (CCs). STs 613 
for which MRSP phenotypes are reported in the MLST database are highlighted in black boxes. 614 
STs for which genomes have been sequenced are highlighted in boxes as follows, light blue = 615 
MSSP, dark blue = MDR-MSSP, pink = MRSP, red = MDR-MRSP. This figure appears in colour in 616 
the online version of JAC and in black and white in the print version of JAC. 617 
Figure 3. Pairwise comparison of representative Staphylococcus pseudintermedius genomes. 618 
The alignment of genome sequences from ED99, 69687, 23929, 1726 and HKU10-03 are 619 
displayed in Artemis Comparison Tool. Red bars present orthologue matches identified by 620 
FASTA analysis. Mobile genetic elements (MGEs) including Staphylococcal cassette 621 
chromosome (SCC)mec elements, transposons, plasmids, prophages and S. pseudintermedius 622 
pathogenicity islands (SpPIs) are shown as coloured boxes. This figure appears in colour in the 623 
online version of JAC and in black and white in the print version of JAC. 624 
 625 
Figure 4. Comparison of SCCmec elements from Staphylococcus pseudintermedius genomes. 626 
The SCCmecII-III element from ST71 (69687) is compared to SCCmecIV from ST261 (1726), and 627 
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SCCmecV(T) from ST68 (23929). Homology is indicated by a colour scale of blue (100% 628 
homology) to grey (78% homology). Genes are coloured by function mecA in red, mecRI in pink, 629 
ccr in yellow, type I restriction-modification (R-M) system genes in blue, type II R-M system 630 
genes in light blue, and clustered regularly interspaced short planidromic repeat (CRISPR) 631 
system genes in green. Figure produced using EasyFig and usingSCCmecII-III element sequence 632 
from 69876*. This figure appears in colour in the online version of JAC and in black and white in 633 
the print version of JAC. 634 
Figure 5. Comparison of Tn5405-like elements from Staphylococcus pseudintermedius 635 
genomes. The Tn5405-like element from ED99 is compared to Tn5405-like elements from 1726, 636 
E140, 69687, 23929, GL118B and GL117B. Homology is indicated by a colour scale of blue (100% 637 
homology) to grey (89% homology). Genes are coloured by function transposase in red, 638 
antibiotic resistance genes in yellow, topoisomerase genes in green, resolvase genes in light 639 
green, plasmid replication genes in bright blue and plasmid recombination genes in dull blue. 640 
Genes in grey were not homologous to any genes using BLAST. aphA, aadE encode resistance to 641 
aminoglycosides, sat to streptothricin, dfrG to trimethoprim and cat to chloramphenicol. Figure 642 
produced using EasyFig and Tn5405-like element sequence from 69876*. This figure appears in 643 
colour in the online version of JAC and in black and white in the print version of JAC. 644 
Figure S1. Comparison of representative prophage from Staphylococcus pseudintermedius 645 
strains. A representative prophage from each of the 8 insertion sites is shown. Homology is 646 
indicated by a colour scale of blue (100% homology) to grey (84% homology). The prophages are 647 
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named by insertion site (X) and then the genome from which the sequence originates. Figure 648 
produced using EasyFig.  649 
Figure S2. Comparison of SpPI1 from Staphylococcus pseudintermedius strains. The 650 
pathogenicity island SpPI1 from ED99 is compared to SpPI1 elements from other sequenced S. 651 
pseudintermedius strains. Homology is indicated by a colour scale of blue (100% homology) to 652 
grey (84% homology). SpPI1 genes are coloured pink, and integrase genes in red. Gene names 653 
are shown for genes that were homologous to annotated genes by pBLAST. Figure produced 654 
using EasyFig. *Note that Tn5405-like elements sequence from BNG1 and 69876 was used to 655 
create the figure.  656 
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Strain Phenotypic 
group 
Country/ 
year/ isolation 
site 
Phenotypic 
Resistance profile 
No Ab 
classes 
resistance 
MLST Total Yield Kb 
(~ fold 
coverage) 
Number 
of 
contigs 
Genome 
size 
(bp) 
GC 
content 
CDS 
number 
GenBank 
Accession 
69687 MDR-MRSP UK/ 
2012/skin 
OXA-PEN-AMP-AMC-
CL-GEN-KAN-ERY-
CLI-SXT-CIP 
7 71 346678 (128x) 130 2,712,000 37.4% 2,651 ERR163420 
69876 MDR-MRSP UK/ 
2012/ear 
OXA-PEN-AMP-AMC-
CL-GEN-KAN-ERY-
CLI-SXT-CIP 
7 71 407664 (150x) 135 2,711,724 37.4% 2,695 ERR144842 
HH15 MDR-MRSP Germany/ 
2012/skin 
OXA-PEN-AMP-AMC-
CL-GEN-KAN-ERY-
CLI-TET-SXT-CIP 
7 71 592337 (213x) 160 2,780,805 37.3% 2,747 ERR144844 
GL119A MDR-MRSP Germany/ 
2012/skin 
OXA-PEN-AMP-AMC-
CL-GEN-KAN-ERY-
CLI-SXT-CIP 
7 71 395970 (144x) 147 2,749,309 37.4% 2,784 ERR294366 
GL151A MDR-MRSP Germany/ 
2012/wound 
OXA-PEN-AMP-AMC-
CL-GEN-KAN-ERY-
CLI-TET-SXT-CIP 
7 71 359894 (131x) 156 2,753,286 37.3% 2,741 ERR294367 
23929 MDR-MRSP Ireland/  
2008/skin 
OXA-PEN-AMP-CL-
KAN-ERY-CLI-TET-
SXT-CIP 
7 68 322943 (118x) 157 2,742,394 37.3% 2,739 ERR175868 
1726 MDR-MRSP UK/ 
2007/ear 
OXA-PEN-AMP-KAN-
ERY-TET-SXT 
5 261 312702 (120x) 120 2,612,150 37.5% 2,568 ERR144810 
BNG1 MRSP UK/ 
Apr2011/skin 
OXA-PEN-AMP-CL-
TET 
2 260 378309 (142x) 113 2,659,338 37.3% 2,608 ERR144839 
BNG3 MRSP UK/ 
Sep2011/skin 
OXA-PEN-AMP-CL-
TET 
2 260 395712 (150x) 160 2,646,594 37.4% 2,597 ERR144767 
GL117B MDR-MSSP Germany/ 
2012/ear 
PEN-AMP-KAN-ERY 3 263 419305 (166x) 148 2,532,911 37.6% 2,488 ERR310922 
GL118B MDR-MSSP Germany/ 
2012/skin 
PEN-AMP-KAN-TET 3 262 454726 (180x) 117 2,527,818 37.6% 2,467 ERR310921 
463949 MSSP USA/ 
2012/skin  
PEN-AMP-TET 2 309 425893 (169x) 76 2,523,489 37.6% 2,463 ERR294364 
ED99 MDR-MSSP UK/  
2005 
PEN-AMP-KAN-ERY-
TET-SXT 
5 25 - - 2,572,216 37.6% 2,401 NC_017568 
HKU10-03 MSSP China/ 
unknown 
unknown - 308 - - 2,617,381 37.5% 2,451 NC_014925 
E140 MDR-MRSP* Denmark/ 
2009 
unknown - 71 - - 2,769,458 38.0% 2,678 ANOI01000001 
MEAN - - - - - 401011 (151x) 135 2,660,725 37.48% 2,605  
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Table 1:  Antimicrobial resistance and general genome characteristics of sequenced Staphylococcus pseudintermedius. All S. 669 
pseudintermedius strains originate from clinical infections. For each isolate and genome, the phenotypic group, country origin and 670 
year of isolation, resistance phenotype, number of antimicrobial classes the isolate is resistant to, 7-gene multilocus sequence type 671 
(MLST)(54), total yield, fold coverage, number of contigs assembled, genome size, GC contents and number of coding domain 672 
sequences (CDS) are shown. MSSP: phenotypic susceptibility to oxacillin and mecA-negative, and resistant to antimicrobials in <3 673 
antimicrobial classes. MRSP: phenotypic resistance to oxacillin and mecA-positive, and resistant to antimicrobials in <3 antimicrobial 674 
classes. MDR-MSSP: phenotypic susceptibility to oxacillin and mecA-negative, and resistant to antimicrobials in ≥3 antimicrobial 675 
classes. MDR-MRSP: phenotypic resistance to oxacillin and mecA-positive, and resistant to antimicrobials in ≥3 antimicrobial classes. 676 
OXA: oxacillin. PEN: penicillin. AMP: ampicillin. AMC: amoxicillin/clavulanate. CL: cefalexin. GEN: gentamicin. KAN: kanamycin. ERY: 677 
erythromycin. CLI: clindamycin. TET: tetracycline. SXT: Trimethoprim/sulfamethoxazole. CIP: ciprofloxacin. RIF: rifampicin. All 678 
phenotypic resistances could be putatively assigned to a genetic determinant in all isolates. *Phenotype not published but assumed 679 
based on ST71.26 680 
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